Stay updated on RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial
Sign up to get notified when there's something new on the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page.

Latest updates to the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays Revision: v3.4.2. The funding-lapse notice and the prior Revision: v3.4.1 text have been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding lapse and NIH operations was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page adds a 'Show glossary' option and updates several metadata labels (e.g., 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a new 'Revision: v3.4.0' tag), while removing the previous labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4').SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedThe Locations section was expanded to include Arizona, California, Colorado, Illinois, Indiana, Kentucky, Massachusetts, Nevada, North Carolina, North Dakota, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, and Virginia with revision v3.3.3, while the HHS Vulnerability Disclosure and the previously listed state locations were removed.SummaryDifference2%

- Check92 days agoChange DetectedThe page footer now shows Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

Stay in the know with updates to RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page.